Paul B Cleveland - Net Worth and Insider Trading
Paul B Cleveland Net Worth
The estimated net worth of Paul B Cleveland is at least $0 dollars as of 2024-11-13. Paul B Cleveland is the Director of Sangamo Therapeutics Inc and owns about 0 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $0. Details can be seen in Paul B Cleveland's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul B Cleveland has not made any transactions after 2014-01-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul B Cleveland
Paul B Cleveland Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul B Cleveland owns 5 companies in total, including Alder BioPharmaceuticals Inc (ALDR) , Adverum Biotechnologies Inc (ADVM) , and Sangamo Therapeutics Inc (SGMO) among others .
Click here to see the complete history of Paul B Cleveland’s form 4 insider trades.
Insider Ownership Summary of Paul B Cleveland
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ALDR | Alder BioPharmaceuticals Inc | 2019-10-22 | director |
ADVM | Adverum Biotechnologies Inc | 2015-12-09 | director & President and CEO |
SGMO | Sangamo Therapeutics Inc | 2015-06-22 | director |
2014-06-19 | President and CFO | ||
2010-09-22 | EVP & Corp. Development and CFO |
Paul B Cleveland Latest Holdings Summary
Paul B Cleveland currently owns a total of 1 stock. Paul B Cleveland owns 0 shares of Sangamo Therapeutics Inc (SGMO) as of January 15, 2014, with a value of $0.
Latest Holdings of Paul B Cleveland
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SGMO | Sangamo Therapeutics Inc | 2014-01-15 | 0 | 2.71 | 0 |
Holding Weightings of Paul B Cleveland
Paul B Cleveland Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul B Cleveland has made a total of 0 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years. The most-recent trade in Sangamo Therapeutics Inc is the sale of 8,333 shares on January 15, 2014, which brought Paul B Cleveland around $155,660.
Insider Trading History of Paul B Cleveland
- 1
Paul B Cleveland Trading Performance
Paul B Cleveland Ownership Network
Ownership Network List of Paul B Cleveland
Ownership Network Relation of Paul B Cleveland
Paul B Cleveland Owned Company Details
What does Alder BioPharmaceuticals Inc do?
Who are the key executives at Alder BioPharmaceuticals Inc?
Paul B Cleveland is the director of Alder BioPharmaceuticals Inc. Other key executives at Alder BioPharmaceuticals Inc include 10 percent owner H Lundbeck A S , Chief Medical Officer Paul Streck , and Chief Financial Officer Carlos Campoy .
Alder BioPharmaceuticals Inc (ALDR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alder BioPharmaceuticals Inc (ALDR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alder BioPharmaceuticals Inc (ALDR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alder BioPharmaceuticals Inc (ALDR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alder BioPharmaceuticals Inc Insider Transactions
Paul B Cleveland Mailing Address
Above is the net worth, insider trading, and ownership report for Paul B Cleveland. You might contact Paul B Cleveland via mailing address: C/o Affymax, Inc., 4001 Miranda Ave., Palo Alto Ca 94304.